美股异动｜泰诺母公司Kenvue盘前反弹超6%，驳斥“对乙酰氨基酚可能导致自闭症”的说法

Group 1 - Kenvue's stock experienced a decline of approximately 7.5% yesterday, followed by a pre-market rebound of over 6%, reaching $18.02 [1] - President Trump warned pregnant women against using Tylenol, citing a potential link between acetaminophen and autism, despite the lack of widely accepted scientific evidence [1] - Kenvue issued a statement asserting confidence in independent and reliable scientific evidence that acetaminophen does not cause autism, strongly opposing contrary claims [1]